Cancer Biological Toxins Drug Market - Global Outlook and Forecast 2021-2027

March 2021 | 91 pages | ID: CCBA991BD6CEEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Cancer Biological Toxins Drug in Global, including the following market information:

Global Cancer Biological Toxins Drug Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Cancer Biological Toxins Drug market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Biological Toxins Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cancer Biological Toxins Drug Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Cancer Biological Toxins Drug Market Segment Percentages, By Type, 2020 (%)

• Hormonal Therapy
• Immunotherapy
• Targeted Therapy

China Cancer Biological Toxins Drug Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Cancer Biological Toxins Drug Market Segment Percentages, By Application, 2020 (%)

• Hospital
• Laboratory
• Others

Global Cancer Biological Toxins Drug Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Cancer Biological Toxins Drug Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Cancer Biological Toxins Drug Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Cancer Biological Toxins Drug Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Amgen Inc.
• AstraZeneca PLC
• Bayer AG
• Bristol-Myers Squibb Company
• Celgene Corporation
• Exelixis, Inc.
• Merck
• Pfizer Inc,
• Sanofi

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cancer Biological Toxins Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cancer Biological Toxins Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CANCER BIOLOGICAL TOXINS DRUG OVERALL MARKET SIZE

2.1 Global Cancer Biological Toxins Drug Market Size: 2021 VS 2027
2.2 Global Cancer Biological Toxins Drug Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cancer Biological Toxins Drug Players in Global Market
3.2 Top Global Cancer Biological Toxins Drug Companies Ranked by Revenue
3.3 Global Cancer Biological Toxins Drug Revenue by Companies
3.4 Top 3 and Top 5 Cancer Biological Toxins Drug Companies in Global Market, by Revenue in 2020
3.5 Global Companies Cancer Biological Toxins Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Biological Toxins Drug Players in Global Market
  3.6.1 List of Global Tier 1 Cancer Biological Toxins Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cancer Biological Toxins Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Cancer Biological Toxins Drug Market Size Markets, 2021 & 2027
  4.1.2 Hormonal Therapy
  4.1.3 Immunotherapy
  4.1.4 Targeted Therapy
4.2 By Type - Global Cancer Biological Toxins Drug Revenue & Forecasts
  4.2.1 By Type - Global Cancer Biological Toxins Drug Revenue, 2016-2021
  4.2.2 By Type - Global Cancer Biological Toxins Drug Revenue, 2022-2027
  4.2.3 By Type - Global Cancer Biological Toxins Drug Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cancer Biological Toxins Drug Market Size, 2021 & 2027
  5.1.2 Hospital
  5.1.3 Laboratory
  5.1.4 Others
5.2 By Application - Global Cancer Biological Toxins Drug Revenue & Forecasts
  5.2.1 By Application - Global Cancer Biological Toxins Drug Revenue, 2016-2021
  5.2.2 By Application - Global Cancer Biological Toxins Drug Revenue, 2022-2027
  5.2.3 By Application - Global Cancer Biological Toxins Drug Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Cancer Biological Toxins Drug Market Size, 2021 & 2027
6.2 By Region - Global Cancer Biological Toxins Drug Revenue & Forecasts
  6.2.1 By Region - Global Cancer Biological Toxins Drug Revenue, 2016-2021
  6.2.2 By Region - Global Cancer Biological Toxins Drug Revenue, 2022-2027
  6.2.3 By Region - Global Cancer Biological Toxins Drug Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Cancer Biological Toxins Drug Revenue, 2016-2027
  6.3.2 US Cancer Biological Toxins Drug Market Size, 2016-2027
  6.3.3 Canada Cancer Biological Toxins Drug Market Size, 2016-2027
  6.3.4 Mexico Cancer Biological Toxins Drug Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Cancer Biological Toxins Drug Revenue, 2016-2027
  6.4.2 Germany Cancer Biological Toxins Drug Market Size, 2016-2027
  6.4.3 France Cancer Biological Toxins Drug Market Size, 2016-2027
  6.4.4 U.K. Cancer Biological Toxins Drug Market Size, 2016-2027
  6.4.5 Italy Cancer Biological Toxins Drug Market Size, 2016-2027
  6.4.6 Russia Cancer Biological Toxins Drug Market Size, 2016-2027
  6.4.7 Nordic Countries Cancer Biological Toxins Drug Market Size, 2016-2027
  6.4.8 Benelux Cancer Biological Toxins Drug Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Cancer Biological Toxins Drug Revenue, 2016-2027
  6.5.2 China Cancer Biological Toxins Drug Market Size, 2016-2027
  6.5.3 Japan Cancer Biological Toxins Drug Market Size, 2016-2027
  6.5.4 South Korea Cancer Biological Toxins Drug Market Size, 2016-2027
  6.5.5 Southeast Asia Cancer Biological Toxins Drug Market Size, 2016-2027
  6.5.6 India Cancer Biological Toxins Drug Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Cancer Biological Toxins Drug Revenue, 2016-2027
  6.6.2 Brazil Cancer Biological Toxins Drug Market Size, 2016-2027
  6.6.3 Argentina Cancer Biological Toxins Drug Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cancer Biological Toxins Drug Revenue, 2016-2027
  6.7.2 Turkey Cancer Biological Toxins Drug Market Size, 2016-2027
  6.7.3 Israel Cancer Biological Toxins Drug Market Size, 2016-2027
  6.7.4 Saudi Arabia Cancer Biological Toxins Drug Market Size, 2016-2027
  6.7.5 UAE Cancer Biological Toxins Drug Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Amgen Inc.
  7.1.1 Amgen Inc. Corporate Summary
  7.1.2 Amgen Inc. Business Overview
  7.1.3 Amgen Inc. Cancer Biological Toxins Drug Major Product Offerings
  7.1.4 Amgen Inc. Cancer Biological Toxins Drug Revenue in Global (2016-2021)
  7.1.5 Amgen Inc. Key News
7.2 AstraZeneca PLC
  7.2.1 AstraZeneca PLC Corporate Summary
  7.2.2 AstraZeneca PLC Business Overview
  7.2.3 AstraZeneca PLC Cancer Biological Toxins Drug Major Product Offerings
  7.2.4 AstraZeneca PLC Cancer Biological Toxins Drug Revenue in Global (2016-2021)
  7.2.5 AstraZeneca PLC Key News
7.3 Bayer AG
  7.3.1 Bayer AG Corporate Summary
  7.3.2 Bayer AG Business Overview
  7.3.3 Bayer AG Cancer Biological Toxins Drug Major Product Offerings
  7.3.4 Bayer AG Cancer Biological Toxins Drug Revenue in Global (2016-2021)
  7.3.5 Bayer AG Key News
7.4 Bristol-Myers Squibb Company
  7.4.1 Bristol-Myers Squibb Company Corporate Summary
  7.4.2 Bristol-Myers Squibb Company Business Overview
  7.4.3 Bristol-Myers Squibb Company Cancer Biological Toxins Drug Major Product Offerings
  7.4.4 Bristol-Myers Squibb Company Cancer Biological Toxins Drug Revenue in Global (2016-2021)
  7.4.5 Bristol-Myers Squibb Company Key News
7.5 Celgene Corporation
  7.5.1 Celgene Corporation Corporate Summary
  7.5.2 Celgene Corporation Business Overview
  7.5.3 Celgene Corporation Cancer Biological Toxins Drug Major Product Offerings
  7.5.4 Celgene Corporation Cancer Biological Toxins Drug Revenue in Global (2016-2021)
  7.5.5 Celgene Corporation Key News
7.6 Exelixis, Inc.
  7.6.1 Exelixis, Inc. Corporate Summary
  7.6.2 Exelixis, Inc. Business Overview
  7.6.3 Exelixis, Inc. Cancer Biological Toxins Drug Major Product Offerings
  7.6.4 Exelixis, Inc. Cancer Biological Toxins Drug Revenue in Global (2016-2021)
  7.6.5 Exelixis, Inc. Key News
7.7 Merck
  7.7.1 Merck Corporate Summary
  7.7.2 Merck Business Overview
  7.7.3 Merck Cancer Biological Toxins Drug Major Product Offerings
  7.4.4 Merck Cancer Biological Toxins Drug Revenue in Global (2016-2021)
  7.7.5 Merck Key News
7.8 Pfizer Inc,
  7.8.1 Pfizer Inc, Corporate Summary
  7.8.2 Pfizer Inc, Business Overview
  7.8.3 Pfizer Inc, Cancer Biological Toxins Drug Major Product Offerings
  7.8.4 Pfizer Inc, Cancer Biological Toxins Drug Revenue in Global (2016-2021)
  7.8.5 Pfizer Inc, Key News
7.9 Sanofi
  7.9.1 Sanofi Corporate Summary
  7.9.2 Sanofi Business Overview
  7.9.3 Sanofi Cancer Biological Toxins Drug Major Product Offerings
  7.9.4 Sanofi Cancer Biological Toxins Drug Revenue in Global (2016-2021)
  7.9.5 Sanofi Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cancer Biological Toxins Drug Market Opportunities & Trends in Global Market
Table 2. Cancer Biological Toxins Drug Market Drivers in Global Market
Table 3. Cancer Biological Toxins Drug Market Restraints in Global Market
Table 4. Key Players of Cancer Biological Toxins Drug in Global Market
Table 5. Top Cancer Biological Toxins Drug Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Cancer Biological Toxins Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Cancer Biological Toxins Drug Revenue Share by Companies, 2016-2021
Table 8. Global Companies Cancer Biological Toxins Drug Product Type
Table 9. List of Global Tier 1 Cancer Biological Toxins Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Biological Toxins Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Cancer Biological Toxins Drug Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Cancer Biological Toxins Drug Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Cancer Biological Toxins Drug Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Cancer Biological Toxins Drug Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Cancer Biological Toxins Drug Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Cancer Biological Toxins Drug Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Cancer Biological Toxins Drug Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Cancer Biological Toxins Drug Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Cancer Biological Toxins Drug Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Cancer Biological Toxins Drug Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Cancer Biological Toxins Drug Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Cancer Biological Toxins Drug Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Cancer Biological Toxins Drug Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Cancer Biological Toxins Drug Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Cancer Biological Toxins Drug Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Cancer Biological Toxins Drug Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Cancer Biological Toxins Drug Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Cancer Biological Toxins Drug Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Cancer Biological Toxins Drug Revenue, (US$, Mn), 2022-2027
Table 30. Amgen Inc. Corporate Summary
Table 31. Amgen Inc. Cancer Biological Toxins Drug Product Offerings
Table 32. Amgen Inc. Cancer Biological Toxins Drug Revenue (US$, Mn), (2016-2021)
Table 33. AstraZeneca PLC Corporate Summary
Table 34. AstraZeneca PLC Cancer Biological Toxins Drug Product Offerings
Table 35. AstraZeneca PLC Cancer Biological Toxins Drug Revenue (US$, Mn), (2016-2021)
Table 36. Bayer AG Corporate Summary
Table 37. Bayer AG Cancer Biological Toxins Drug Product Offerings
Table 38. Bayer AG Cancer Biological Toxins Drug Revenue (US$, Mn), (2016-2021)
Table 39. Bristol-Myers Squibb Company Corporate Summary
Table 40. Bristol-Myers Squibb Company Cancer Biological Toxins Drug Product Offerings
Table 41. Bristol-Myers Squibb Company Cancer Biological Toxins Drug Revenue (US$, Mn), (2016-2021)
Table 42. Celgene Corporation Corporate Summary
Table 43. Celgene Corporation Cancer Biological Toxins Drug Product Offerings
Table 44. Celgene Corporation Cancer Biological Toxins Drug Revenue (US$, Mn), (2016-2021)
Table 45. Exelixis, Inc. Corporate Summary
Table 46. Exelixis, Inc. Cancer Biological Toxins Drug Product Offerings
Table 47. Exelixis, Inc. Cancer Biological Toxins Drug Revenue (US$, Mn), (2016-2021)
Table 48. Merck Corporate Summary
Table 49. Merck Cancer Biological Toxins Drug Product Offerings
Table 50. Merck Cancer Biological Toxins Drug Revenue (US$, Mn), (2016-2021)
Table 51. Pfizer Inc, Corporate Summary
Table 52. Pfizer Inc, Cancer Biological Toxins Drug Product Offerings
Table 53. Pfizer Inc, Cancer Biological Toxins Drug Revenue (US$, Mn), (2016-2021)
Table 54. Sanofi Corporate Summary
Table 55. Sanofi Cancer Biological Toxins Drug Product Offerings
Table 56. Sanofi Cancer Biological Toxins Drug Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Cancer Biological Toxins Drug Segment by Type
Figure 2. Cancer Biological Toxins Drug Segment by Application
Figure 3. Global Cancer Biological Toxins Drug Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Cancer Biological Toxins Drug Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Cancer Biological Toxins Drug Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Biological Toxins Drug Revenue in 2020
Figure 8. By Type - Global Cancer Biological Toxins Drug Revenue Market Share, 2016-2027
Figure 9. By Application - Global Cancer Biological Toxins Drug Revenue Market Share, 2016-2027
Figure 10. By Region - Global Cancer Biological Toxins Drug Revenue Market Share, 2016-2027
Figure 11. By Country - North America Cancer Biological Toxins Drug Revenue Market Share, 2016-2027
Figure 12. US Cancer Biological Toxins Drug Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Cancer Biological Toxins Drug Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Cancer Biological Toxins Drug Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Cancer Biological Toxins Drug Revenue Market Share, 2016-2027
Figure 16. Germany Cancer Biological Toxins Drug Revenue, (US$, Mn), 2016-2027
Figure 17. France Cancer Biological Toxins Drug Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Cancer Biological Toxins Drug Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Cancer Biological Toxins Drug Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Cancer Biological Toxins Drug Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Cancer Biological Toxins Drug Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Cancer Biological Toxins Drug Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Cancer Biological Toxins Drug Revenue Market Share, 2016-2027
Figure 24. China Cancer Biological Toxins Drug Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Cancer Biological Toxins Drug Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Cancer Biological Toxins Drug Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Cancer Biological Toxins Drug Revenue, (US$, Mn), 2016-2027
Figure 28. India Cancer Biological Toxins Drug Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Cancer Biological Toxins Drug Revenue Market Share, 2016-2027
Figure 30. Brazil Cancer Biological Toxins Drug Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Cancer Biological Toxins Drug Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Cancer Biological Toxins Drug Revenue Market Share, 2016-2027
Figure 33. Turkey Cancer Biological Toxins Drug Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Cancer Biological Toxins Drug Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Cancer Biological Toxins Drug Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Cancer Biological Toxins Drug Revenue, (US$, Mn), 2016-2027
Figure 37. Amgen Inc. Cancer Biological Toxins Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. AstraZeneca PLC Cancer Biological Toxins Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Bayer AG Cancer Biological Toxins Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Bristol-Myers Squibb Company Cancer Biological Toxins Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Celgene Corporation Cancer Biological Toxins Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Exelixis, Inc. Cancer Biological Toxins Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Merck Cancer Biological Toxins Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Pfizer Inc, Cancer Biological Toxins Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Sanofi Cancer Biological Toxins Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)